Czuczman Myron 4
4 · Citius Pharmaceuticals, Inc. · Filed Nov 12, 2024
Insider Transaction Report
Form 4
Czuczman Myron
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Purchase Common Stock)
2024-11-07+300,000→ 300,000 totalExercise: $0.38Exp: 2034-11-07→ Common Stock (300,000 underlying)
Holdings
- 300,000
Stock Option (Right to Purchase Common Stock)
Exercise: $0.70Exp: 2033-10-10→ Common Stock (300,000 underlying) - 300,000
Stock Option (Right to Purchase Common Stock)
Exercise: $2.04Exp: 2031-10-11→ Common Stock (300,000 underlying) - 300,000
Stock Option (Right to Purchase Common Stock)
Exercise: $1.25Exp: 2032-10-04→ Common Stock (300,000 underlying) - 500,000
Stock Option (Right to Purchase Common Stock)
Exercise: $1.19Exp: 2030-07-14→ Common Stock (500,000 underlying)
Footnotes (4)
- [F1]The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F2]The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F3]The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F4]The options are fully vested and exercisable immediately.